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Abstract 
Background To characterize the molecular and functional 
status of the rat retina and optic nerve after acute elevation 
of intraocular pressure (IOP). 
Methods Retinal ischemia was induced in rats by increasing 
the IOP (110 mmHg/60 minutes). Microarray analysis, quan-
titative RT-PCR (qRT-PCR) and immunohistochemistty were 
used to charactetize retinal tissue. PLGA microspheres contain-
ing neurotrophic factors (BDNF, GDNF, or CNTF) or empty 
microspheres were injected into the vitreous of operated animals 
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1 day after elevation oflOP. Pupil light reflex (PLR) parameters 
and electroretinograms (ERG) were monitored at multiple time 
points <luting the 60-day postoperative recovery period. 
Results Molecular analysis showed a significant intrinsic 
up-regulation of CNTF at 10 and 25 days after induction of 
the acute ocular hypertension (p=0.0067). Molecular tissue 
analysis of GDNF and its receptors (GDNFRl, GDNFR2), 
and BDNF and its receptor (trkB) showed no change in 
expression. Animals that received CNTF microspheres had 
no significant functional recovery compared to animals 
which received blank microspheres (p>0.05). Animals that 
received GDNF or BDNF microspheres showed significant 
PLR recovery (p<0.05 and p<0.001 respectively) com-
pared to non-treated animals. 
Conclusions Continuous release of neurotrophic growth 
factors (NGFs) significantly protects optic nerve function 
in the experimental model of retinal ischemia observed by 
PLR analysis. 
Keywords Neuroprotection ·Retina· BDNF · GDNF · 
CNTF 
Introduction 
Ischemic insults to the retina and optic nerve often lead to 
blindness due to serious perturbation of neuronal and glial 
retinal elements. Currently, glaucoma and ischemic disor-
ders of the eye, including diabetes, ischemic optic neurop-
athy and retinal vascular occlusions are among the most 
prevalent causes of blindness worldwide. 
Numerous studies have demonstrated that the rat model of 
acute elevation of intraocular pressure is a useful model for 
studying not only retinal ganglion cell damage, but also pan-
retinal changes caused by retinal ischemic disorders [l, 2]. 
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The presence of ischemic damage to all retinal neuronal cell 
types provides a unique advantage of testing possible neuro-
protective molecules and their biological effect on different 
sub-populations ofretinal neurons. By this approach, screen-
ing time for the best candidate molecules can be dramatically 
shortened, and successful therapeutic molecules can be further 
validated in specific animal models in which pathological 
changes affect defined neuronal populations. 
Ischemic retinal and optic nerve diseases (glaucoma and 
diabetic retinopathy being the most frequent ones) are 
characterized by the development of progressive visual field 
defects and retinal neuronal death [3, 4]. Unfortunately, in 
many patients, despite adequate control of the IOP or 
glucose levels, the loss of vision continues. 
Current medical and surgicat treatments can achieve 
control of the IOP in glaucomatous patients, or provide 
increased vascularization and/or oxygenation in patients with 
different retinal/optic nerve ischemic diseases. However, there 
are still no adequate treatments that provide protection of 
remaining healthy neurons and/or recovers function in retinal 
neurons already compromised by the disease process. This 
necessitates development of alternative therapeutic strategies 
that could act directly on the retinal neurons to promote their 
survival, even in situations where the causative mechanism of 
damage (e.g. elevated IOP and ischemia due to completely or 
pa1tially obstructed retinal blood vessels, diabetes) is still not 
well-controlled. It has been previously demonstrated that 
exogenous application of neurotrophic factors can promote 
survival in glaucoma [5-9] and in eyes with different forms 
ofretinal degeneration [ 10-14]. We previously demonstrated 
that rodent retinas exposed to acute and chronic elevation of 
IOP are capable of significant intrinsic, but tempora1y, 
recove1y of the retina and optic nerve function [ 15-17], 
suggestive of intrinsic ocular mechanisms capable of 
preserving retinal function and structure. 
We had two separate goals for this study. The first goal 
was to characterize expression profile of genes, which may 
be responsible for the observed temporary functional 
recove1y in rodent eyes exposed to acute elevation of 
intraocular pressure, with a paiticular focus on neurotrophic 
growth factor expression. The second goal was to evaluate 
whether exogenous application of neurotrophic factors can 
modulate (increase or decrease) functional and morpholog-
ical recovery in ischemic retinas. 
Materials and methods 
Induction of retinal ischemia by elevated intraocular 
pressure (IOP) 
All animal studies were conducted in accordance with the 
ARVO Statement for Use of Animals in Ophthalmic and 
©Springer 
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Vision Research, principles of laboratory animal care" (NIH 
publication No. 85-23, revised 1985), the OPRR Public 
Health Service Policy on the Humane Care and Use of 
Laboratoty Animals (revised 1986), and the U.S. Animal 
Welfare Act, and procedures were approved by the Iowa 
State University Committee on Animal Care. Procedure to 
generate an ischemia-reperfusion insult in rats was 
performed as previously described [17]. Briefly, adult 
Brown Norway rats (n=63) were initially anesthetized 
with 4% halothane, 30% nitrous oxide (NO) and 70% 
oxygen (02). Anesthesia was maintained with 2.5% 
halothane, 30% NO and 70% 0 2, and body temperature 
was maintained using a heating pad. The pupils were 
dilated with topical 2.5% phenylephrine hydrochloride 
and 1 % tropicamide. After topical instillation of 0.5% 
propracaine hydrochloride, the anterior chamber was 
cannulated with a 25-gauge needle connected to a 
reservoir containing 0.9% NaCl. The IOP in experimental 
eyes was controlled by the height of the reservoir to 
maintain a pressure of 110 mmHg for 60 minutes. Retinal 
ischemia was confirmed by the blanching of the iris and 
retinal circulation. At the end of the period of elevated 
IOP, the needle was removed, and reperfusion of the 
retinal vasculature was confirmed by ophthalmoscopic 
examination. To prevent potential infection, antibiotic 
ointment (neomycin + polymyxin B + bacitracin; Bausch 
& Lomb Pharmaceuticals Inc; Tampa, FL, USA) was 
applied topically after the procedure. After surgery, pain 
was controlled by acetaminophen (100 mg/kg) + codeine 
(75 mg/kg) in the drinking water for 3 days. 
Molecular profiling 
Groups of five rats were sacrificed at 10, 25 and 42 days 
after acute elevation of IOP. Retinal tissue was collected for 
microarray and qRT-PCR analysis and immunohistochem-
ical analysis. 
lmmunohistochemical analysis 
For antibody staining, retinal tissue sections were washed in 
phosphate buffered saline (PBS; 13 7 mM NaCl, 
2.68 mM KC!, 8.1 mM Na2 HP04, 1.47 mM KH2P04) 
and incubated in blocking solution [5% goat serum; 0.4% 
bovine serum albumin, BSA (Sigma, St. Louis, MO, USA), 
and 0.2% Triton X-100 (Fisher Scientific)] in PBS. A 
specific primary antibody directed against CNTF alpha 
(Antibodies Inc., Davis, CA, USA) was used at a dilution 
of 1 :250 and diluted in blocking solution, and preparations 
incubated overnight at 4°C in a humid chamber. On the 
following day, the preparations were rinsed with PBS and 
incubated with Cy3 conjugated donkey-anti-goat secondary 
antibody (Jackson ImmunoResearch, West Grove, PA, 
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USA) diluted at 1: 1,000 in blocking solution for 90 minutes 
at room temperature. Sections were washed in PBS and 
cover-slipped with Gelmount Mounting media (Fisher). 
Negative controls were run in parallel during all processing, 
and included the omission of the primary antibody and/or 
secondary antibody, and no non-specific labeling was 
observed under these conditions. 
Microarray and quantitative RT-PCR analyses 
Total retinal RNA was extracted from retinas of rat eyes 
using Qiagen RNeasy (Qiagen, Valencia, CA, USA) 
columns and treated with DNAse. The quantity and quality 
of total RNA was determined (Bioanalyzer; Agilent, Santa 
Clara, CA, USA). Two micrograms of total RNA from 
each individual retina in each ,experimental group was 
pooled for microarray studies, which were performed using 
array chips (Rat Genome 230 2.0; Affymetrix, Santa Clara, 
CA, USA). All hybridizations were performed at the 
University of Iowa Microarray Core Facility. Quantitative 
RT-PCR analysis was perfo1med for by using 200 ng 
retinal RNA from each individual animal, which was 
reverse transcribed in a random primed reaction. PCR 
primers were designed to span at least one intron to avoid 
the generation of PCR signal from potentially remaining 
genomic DNA (Table 1). 
Five micrograms of the resulting cDNA was used as 
template for each amplification reaction, and all samples 
were analyzed in triplicate. Samples underwent 35 cycles of 
amplification in an ABI type 7700 machine using SYBR 
Green as the reporter dye (QuantiTect, Qiagen). Amplifi-
cation controls included wells containing genomic DNA 
only and those containing no target (water controls). 
Transcript levels were determined based upon standard 
curves for each primer pair. Melt curve analyses were 
carried out following each amplification reaction to 
ascertain the absence of unspecific amplification products 
or primer dimers. Expression values obtained were normal-
ized to transcript levels for ubiquitin C (UBC) in each 
sample. 
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Microsphere fabrication 
GDNF microsphere .fabrication 
Glial cell lined-derived neurotrophie factor (GDNF) miero-
spheres were fabricated using a modified version of the 
spontaneous emulsification technique as previously de-
scribed [8, 18). Briefly, 200 mg of poly(lactic-eo-glyeolie 
acid) (PLGA) 502H (50:50, Mn~ 10 kDa, Boehringer 
Ingelheim, GmbH, Ingelheim, Ge1many) was dissolved in 
5 ml of a 1 :4 (vol:vol) dicholoromethane (Sigma-Aldrich, 
St. Louis, MO, USA) to trifluoroethanol solution (Sigma-
Aldrich). Ten micrograms of GDNF (R&D Systems, 
Minneapolis, MN, USA), 700 µg bovine serum albumin 
(BSA, Sigma-Aldrich), and 11.125 µg of AOT (Aerosol-
OT, Sodium bis-2-ethylhexyl-sulfosuccinate, Sigma-
Aldrich) were dissolved in 300 µl phosphate-buffered 
saline (PBS). The solutions were vortexed. The subsequent 
emulsion was poured into 200 ml of a 5% (w/v) poly( vinyl 
alcohol) (PVA) solution (Polyseiences, Inc., Warrington, 
PA, USA), which was stitTed to allow for solvent transfer 
and hardening of the microspheres. Following this step, the 
microspheres were collected by centrifugation and washed 
three times in deionized water to remove the residual PVA 
solution from the spheres. The microspheres were then 
quick- frozen in liquid nitrogen, lyophilized overnight and 
stored at-20°C in a dessicator until use. Blank micro-
spheres were made at the same time using the same 
conditions except that no growth factor was added. 
BDNF microsphere .fabrication 
Brain-derived neurotrophic factor (BDNF) microspheres 
were made in a manner identical to the GDNF micro-
spheres, except that a blend of 50% PLGA 502H and 50% 
PLGA-b-plys-g-PEG was substituted for the PLGA 502H. 
PLGA-b-plys-g-PEG was fabricated by coupling PLGA 
502H with poly-L-lysine (Sigma, Mn~lOOO Da, deprotected) 
following [ 19). Methyl-terminated poly( ethylene glycol) 
(PEG) (Polysciences, Warren, PA, USA: Mn~2000 Da) 
Table l Sequence of primers 
used for real-time PCR reactions Gene Forward primer (5'-3') Reverse primer (5'-3') 
GDNF 
GFRAI 
GFRA2 
BDNF 
Tr kB 
CNTF 
CNTFR 
UBC 
AAGTTATGGGATGTCGTGGC 
AAGTCTCTGTACAACTGCCGCT 
AATGAGCTGTGTGCGGCTGAAT 
ATCCACTGAGCAAAGCCGAACT 
CAAGCTGACGAGTTTGTCCA 
TTGTGTCCTGGGACAGTTGA 
ACACCACGGCTATCACCTTC 
ATCTTTGCAGGCAAGCAGCTGGAA 
GTCAGGATAATCTTCGGGCA 
AAGAGCATCCCGTAGCTGTGCTT 
ATCCAGGCAGTGGTTGCTTT 
AGCCTTCATGCAACCGAAGT 
CCTGGAGAGTCTTGAGCCAC 
AGTCGCTCTGCCTCAGTCAT 
ATTCGAGAGCTCCACATGCT 
TCTTGCCTGTCAGGGTCTTCACAA 
~Springer 
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was activated with carbonyldiimidazole (CDI) following [20] 
and [21]. The activated PEG was added to the PLGA-b-plys 
and precipitated in ether. 
CNTF microsphere fabrication 
Ciliary neurotrophic factor (CNTF) microspheres were 
prepared in the same manner as the GDNF microspheres, 
except that 20 µg of CNTF was added, and 98 µg of AOT 
as recently described [22]. 
Characterization of microspheres 
Particle sizing Microspheres were characterized using a 
Beckman Coulter Multisizer 3 apparatus with a 100 µm 
diameter aperture. The mean diameters reported here are 
volume weighted diameters. 
Scanning electron microscopy (SEM) Microspheres were 
sputter coated with gold for 30 s at 25 mA. SEM 
micrographs were taken on a Hitachi S-530 SEM operating 
at 4 kV. 
Release study Three sets each of growth-factor-containing 
and blank microspheres were prepared by adding 1 ml of 
PBS to 10 mg of microspheres. The mixtures were then 
Graefes Arch Clin Exp Ophthalmol (2010) 248:1105-11 lG 
incubated at 3 7°C on a Labquake rotating shaker. At 
specific time points (2, 8 h, 1, 3, 5 days, etc. until no 
pellet could be identified following centrifugation), the 
mixture was centrifuged, and the supernatant was removed. 
Fresh PBS was added, and the microspheres were returned 
to the shaker. The supernatant for each of the sets of 
microspheres was frozen and stored at-80°C for subsequent 
analysis using ELISA kits for specific growth factors (R&D 
Systems, Duo Set) (Fig. 1 ). 
Injection of polymer microspheres 
Twenty four hours postoperatively, rats were anesthetized; 
the conjunctiva! and ocular surface was cleansed with 1:40 
betadine solution and rinsed with a sterile saline solution. 
Microspheres were injected into the vitreous using 
pulled and beveled glass needles with an outer diameter 
of approximately 100 µm at the tip. A 2% suspension of 
microspheres was prepared in PBS (for each growth factor 
separately) and vortexed briefly before each injection to 
ensure a uniform dispersion of spheres in the injection 
mass. Using a 25 µI Hamilton Syringe (Hamilton Co.; 
Reno, NV, USA) connected via PVC tubing to the injection 
needle, 3 µl of 2% suspension of the microspheres was 
injected into the vitreous. 
Fig. 1 Release kinetics of 
PLGA microspheres (a, b, c)-
steady release of neurotrophic 
growth factors was detected for 
at least 60 days (a, BDNF), 
a BDNF microspheres b GDNF microspheres 
80 days (b, GDNF) and 50 days 
(c, CNTF). Scanning electron 
microscopy of the microspheres 
(d). Scale bar in D=50 µm 
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Three different groups of animals received growth-
factor-engineered microspheres containing: BDNF (n= 10), 
CNTF (n=9) or GDNF (n=7). A foutih, control group 
received blank PLGA microspheres (11=9), which were not 
impregnated with growth factors, while a fifth group of rats 
(w=l3) did not receive any injections. 
Computerized pupillometry 
The pupil light reflex was evaluated with a custom-made 
computerized pupillometer (University of Iowa, Iowa City, 
IA, USA) preoperatively and on days 10, 20, 30, 40, 50 and 
60 postoperatively as previously reported [23]. Animals 
whose tissue was collected for molecular analysis were 
recorded at 1, 10, 25 and 42 days postoperatively. Briefly, 
animals were anesthetized initially with 4% halothane, 30% 
NO and 70% 0 2 . A light plane of anesthesia was 
maintained with 1 % halothane, 30% NO and 70% 0 2 to 
avoid suppression of the pupil light reflex response that 
occurs with the use of higher doses of anesthetic. The 
computerized pupillometer was attached to two infrared-
sensitive CCTV video cameras for simultaneous visual 
monitoring of both pupils. However, a single channel 
computerized pupillometer was used to record the move-
ment of the pupil from the control (non-operated) eye, 
while the stimulus light was alternated between the control 
and operated eye. The stimuli were delivered through a 
mask equipped with four green (light-stimulus-delivering) 
and three infrared (iris-illuminating) diodes per eye. 
Custom made software routines (Winnana Software, Uni-
versity of Iowa) were used to analyze the recorded tracings 
of the pupil movements in response to light stimuli and to 
objectively determine the timing and amplitude of the pupil 
reflex responses. Since the opposite, non-operated eye was 
used as a control at the same testing time, any defect which 
was caused by ischemia-reperfusion injury was monitored 
longitudinally over time. 
Electroretinography 
To quantitate post-ischemic recove1y after acute elevation 
of the IOP, electroretinography was performed at 62 days 
post-operatively as previously reported [23]. Briefly, ani-
111als were dark-adapted for at least 6 h, anesthetized as 
described previously and the pupils dilated with 1 % 
tropicamide and 2.5% phenylephrine. The animals were 
placed in a specially designed dome whose interior was 
completely covered with aluminum foil to obtain a 
Ganzfeld effect. Body temperature was maintained using a 
111icrowave-heated thermal pad (R.G. Bany Corporation, 
Pickerington, OH, USA). A light stimulus was delivered 
through the ceiling of the dome using a PS-22 stimulator 
(Grass-Telefactor, West Warwick, RI, USA). Two DTL 
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fiber electrodes (Chieldex Trading GmbH, Palmyra, NY, 
USA), were used to simultaneously obtain signals from 
both eyes. The reference electrode was positioned in the ear, 
while the ground electrode was on the back (subcutaneous). A 
Neuropack-MEB 7102 Evoked Potential Measuring System 
(Nihon-Kohden America, Foothill Ranch, CA, USA) was 
used to deliver a triggered output to the flash stimulator and 
collect signals from both eyes. A flash ERG routine was 
delivered at a 0.2 Hz frequency (ten averaged signals per 
recording session, sensitivity 100 µ V /division, low-cut 
frequency 0.5 Hz, high-cut frequency 10 kHz, analysis time 
500 ms). Oscillatory potentials were recorded by delivering 
light stimuli at a 0.2 Hz frequency (ten averaged signals per 
recording session, sensitivity 100 µ V /division, low-cut 
frequency 50 Hz, high-cut frequency 500 Hz, analysis time 
100 ms). Isolated cone responses were recorded from 
previously light adapted eyes by delivering stimuli at 20 Hz 
( 50 averaged signals per recording session, sensitivity 50 µVI 
division, low-cut frequency 0.5 Hz, high-cut frequency 
10 kHz, analysis time 500 ms). 
Histological examination 
We previously demonstrated that the rat model of acute 
ocular hypertension injury is characterized by severe 
damage of all retinal layers (17). As such, we decided to 
perform morphometric analysis by measuring the thickness 
of different retinal layers in sections obtained at the optic 
nerve head level, as described in our previous studies [ 15, 17]. 
Briefly, 65 days postoperatively, rats were deeply anesthe-
tized with a high dose of phenobarbital (100 mg/kg) and 
perfused intracardially with ice-cold heparinized saline 
followed by 4% paraformaldehyde in 0.1 M phosphate 
buffer. Eye globes containing optic nerves were postfixed, 
paraffin embedded, and 7 µm-thick sections of the retina 
(sections through the optic nerve) were collected onto poly-1-
lysine-coated glass slides, and stained with hematoxylin and 
eosin. Tissue sections were examined with a Nikon Micro-
phot FXA photomicroscope (Nikon Corporation, New York, 
NY, USA). Images were captured using a Kodak Megaplus 
Camera (Model 1.4; Kodak Corp., San Diego, CA, USA) 
connected to a MegaGrabber Framegrabber in a Macintosh 
8100/80 AV computer (Apple Computer, Cupertino, CA, 
USA) using NIH Image 1.58 VDM software (W.Rasband, 
NIH, Bethesda, MD, USA). Sections of the retina at the level 
of the optic nerve head were prepared, and each section was 
divided into 12 optic fields (six fields of the central retina 
and six fields of the peripheral retina). Within each field, 
we measured the thickness of the nerve fiber layer and 
retinal ganglion cell layers (NFL + RGC), inner nuclear 
(INL) and outer nuclear layer (ONL) by measuring four 
values per layer and calculating averaged values per 
section. Measurements of retinal layer thickness were 
~Springer 
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Table 2 Genes down-regulated more than threefold in retinas exposed to acute elevation of!OP. Gene pattern is suggestive of the continuous loss 
of genetic activity associated with essential retinal neuronal functional and structural properties in early and late time points 
Gene title/sequence description 
Nfl, neurofilament, light polypeptide 
Nefh, neurofilament, heavy polypeptide 
Opn l mw, opsin I (cone pigments), medium-wave-sensitive 
(color blindness, deutan), green opsin 
Arr3, aITestin 3, retinal (X-arrestin) 
performed using a calibrated scale of the objective of the 
light microscope. 
Statistical analysis 
Statistical analysis was performed by using Student's t-test, 
paired t-test and one-way ANOVA with Bonferroni post test 
(as indicated in the text) with GraphPad (GraphPad, San 
Diego, CA, USA) software. 
Results 
Molecular profiling to determine the nature of mechanisms 
responsible for spontaneous functional recovery 
Micro array analysis from eyes collected at 10 and 25 days 
post acute elevation of IOP revealed primary down-
regulation of genes related to the basic neuronal and 
photoreceptor structure and function (Table 2), suggestive 
Gene title/sequence description 
Glial activation 
Reference sequence Relative change Relative change 
accession no. 10 days 25 days 
BF394545 6.1 4.9 
AF031879 4.3 3.8 
NM 053548 5.1 3.6 
All 12106 3.8 3.5 
of the continuous process of neuronal death in ischemic 
retinas. Analysis of up-regulated gene expression pattern 
revealed increase in gene activity associated with glial cell 
activity, acute phase protein production and inflammation 
(Table 3). Careful analysis of pro-survival genes and genes 
regulating production of growth factors revealed only 
increased expression of the CNTF gene, which was present 
at 10 (5.4-fold increase compared to control eyes) and 25 
(3.4-fold increase compared to control eyes) days post 
induction of retinal ischemia (Table 3). 
Real-time PCR analysis was used to further evaluate and 
confirm findings obtained by microarray analysis. PCR 
analysis revealed that the gene transcript for CNTF is 
significantly increased (p=0.0067, paired t-test) in ischemic 
retinas: We detected an almost 20-fold increase in the 
expression levels (19.7±23.3 fold, mean± SD) between the 
ischemic eyes and the contralateral, untreated control eyes 
at 10 days. Elevated expression levels could still be 
detected 25 days after induction of retinal ischemia, 
although at reduced levels ( 4.4± 1.3 fold). Analysis of the 
Reference 
sequence 
accession no. 
Relative change 
10 days 
Relative change 
25 days 
Table 3 Genes up-regulated 
more than threefold in retinas 
exposed to acute elevation of 
IOP. Gene pattern is suggestive 
of the persistent glial activation 
and continuous presence of in-
flammatory changes in ischemic 
retinas. The only identified pro-
survival gene with consistent 
up-regulation at both time points 
was the CNTF gene 
Gfap, glial fibrillaiy acidic protein NM_Ol7009 10.6 8.8 
SI 00a4, S 100 calcium-binding protein A4 NM 012618 9.6 8.7 
Vim, vimentin NM 031140 4.6 4 
Acute-phase proteins 
C3, complement component 3 NM_016994 11.9 8.8 
Cp, ceruloplasmin NM_0\2532 7.4 5.6 
A2m, alpha-2 macroglobulin NM 012488 4.8 3.6 
Inflammato1y response 
Litaf, LPS-induced TNF Bl284739 4.2 3.2 
Cd74, CD74 antigen (invariant NM 013069 28.5 28.4 
polpypeptide of major histocompatibility 
class II antigen-associated) 
Cd48, CD48 antigen X13016 5.5 3.4 
Lyz, lysosome Ll2458 12.2 5.5 
Growth factors 
Cntf, ciliary neurotrophic factor NM __ 013166 5.4 3.4 
----
~Springer 
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0 
- 10days 
c::::J 25 days 
CNTF CNTFR 
Fig. 2 Real-time PCR analysis showed significant CNTF mRNA up-
regulation in operated eyes 10 and 25 days postoperatively (horizontal 
line represents ratio value 1, which con~sponds to equal expression of 
mRNA in operated and control eyes). Analysis of CNTF receptor 
(CNTFR) mRNA levels did not reveal significant change between 
ischcmic and control eyes (bars represent mean+ SD) 
CNTF receptor (CNTFR) expression showed that while this 
receptor is expressed in the retina, the ischemia-induced 
expression changes are not statistically significant when 
compared to control eyes (p=0.56, paired t-test): 1.4±0.3 
(mean± SD) expression ratio between the ischemic eyes and 
the ipsilateral, untreated control eyes at 10 days and 1.6± 
0.3 (mean±SD) at 25 days (Fig. 2a). 
Immunohistochemist1y analysis of rat retinas exposed to 
the ischemic insult showed significantly increased CNTF 
protein expression at 25 days post ischemic insult, 
confirming results of the PCR analysis (Fig. 3). 
Analysis of GDNF and its respective receptors (GFRAl, 
GFRA2) did not reveal significant changes in expression 
patterns between control and ischemic eyes (p=0.26; p= 
0.46; p=0.4 respectively): GDNF 10ct=0.94±0.3 (mean ± 
SD), GFRAl ioct=0.9±0.3, GFRA210c1= 1.2±0.3; GDNF25c1= 
Fig. 3 Immunohistochemical analysis showed increased CNTF 
Protein expression at 25 days postoperatively (time interval of 
spontaneous functional recovery). However, protein expression de-
clined at 42 days postoperatively, which corresponded to the decline 
1111 
0.74±0.2, GFRA1 25c1=0.76±0.3, GFRA225ct=0.63±0.3 
(Fig. 4a). Expression analysis for BDNF and its receptor 
Trk B showed a trend toward decreased expression in 
ischemic retinas, however difference was not statistically 
significant (p=0.4 and p=0.06 respectively, paired t-test). 
Values at 10 days post ischemic insult were: BDNF=0.69± 
0.1; TrkB=0.4±0.1 (expression ratio operated/control), and 
they normalized at 25 days post injmy (BDNF=0.85±0.3; 
TrkB=0.78±0.1 expression ratio operated/control, Fig. 4b). 
Assessment of optic nerve function using the pupil light 
reflex (PLR) 
The measurement of the PLR was used as an assay to 
investigate possible changes in retinal and optic nerve 
function following acute elevation of the IOP and subse-
quent neurotrophic growth factor application. The reflex 
contraction of the pupil to a light stimulus provides an 
objective measure of the afferent conduction of the visual 
system. Damage to the retina or optic nerve reduces the 
amplitude of the pupil contraction to light. Since the motor 
output of the neuronal reflex of pupil contraction to light is 
distributed to both pupils, monitoring the pupil from just 
the non-operated eye is sufficient to assess any asymmet1y 
of light input between the operated and non-operated eye. 
Because the fellow eye was used as a control at the same 
testing time, any defect and functional recovery was 
monitored longitudinally over time. All pupil parameters 
were calculated by comparing values from the operated 
and non-operated (control) eyes in the same animal (Figs. 5 
and 6). 
Detailed analysis of PLR amplitudes presented as the 
PLRratio (ratio = consensual/direct PLR) revealed that eyes 
which received blank microspheres or CNTF microspheres 
did not show significant improvement of PLR amplitudes 
in PLR and ERG function in operated animals. Despite intrinsic 
growth factor production, significant inner retina thinning is present at 
42 days postoperatively 
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Fig. 4 a Real-time PCR analysis showed relatively unchanged 
mRNA expression for GDNF and its respective receptors (GFRAl 
and 2) 10 and 25 days post ischemic insult (horizontal line represents 
ratio value of I, which corresponds to' equal expression of mRNA in 
when compared to eyes which received injections of blank 
microspheres (Fig. 5, p=0.051) or eyes which did not 
receive any treatment (p=0.15). 
In contrast, animals which received BDNF or GDNF 
microsphere injections 24 h postoperatively had signifi-
cantly larger PLR amplitudes than the groups which 
received blank microspheres or no microspheres (ANOVA 
with Bonferroni's multiple comparison test). The average 
values for different groups were: PLRratio(BDNF)=54.5± 
1.5% (mean ± SEM, p<0.0001), PLRratio(GDNF)=48± 
3% (p=0.037), PLRratio(CNTF)=44.3± 1.6% (p=0.051 ), 
PLRratio(blank)=39.1.5±1.8% (p=0.43), PLRratio(no 
microspheres)=36.4±4.4%. 
Electroretinography 
Electroretinography was used as an objective method to 
evaluate the functional status of the inner and outer retina with 
a 
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Fig. 5 a Graph shows pupil light reflex data from rodent eyes 
exposed to ischemic insult that received blank microspheres. There 
was no significant difference between the 2 groups. b Graph shows 
the group that received CNTF microspheres. While overall function in 
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operated and control eyes). b Analysis of the BDNF and its respective 
receptor TrkB, showed a trend toward decreased expression at 1 O days; 
however, mRNA levels normalized 25 days post ischemic insult (bars 
represent mean+ SD) 
the exception of the retinal ganglion cells. Electroretinograph-
ic data expressed as a ratio between control and operated eyes 
revealed significantly better cone function (measured by 
flicker ERG amplitudes) in eyes which received GDNF, 
CNTF or blank microspheres compared to eyes which did not 
receive any treatment: GDNFflra1;0 = 10.2±2.9% (mean± 
SEM, p=0.03, Student's t-test), CNTFfl131;0 =8.2±3.1% (p= 
0.04, Student's t-test), blankflratio =9 .2±3 .3% (p=0.04, Stu-
dent's t-test). While application of BDNF microspheres 
showed significant improvement in the PLR function, 
analysis of ERG amplitudes did not show significant 
improvement in any of the observed parameters when 
compared to non-treated eyes. 
Analysis of scotopic flash a-and b-wave amplitudes and 
oscillatory potentials revealed no significant difference 
among different treatment groups for any of the observed 
parameters (Fig. 7). There was no significant difference 
between any of the neurotrophic growth factor groups and 
b90 
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CNTF treated rats was somewhat better difference was not statisti, 
cally significant when compared to 1'.ats which received empty 
microspheres. Values are plotted as mean±SEM 
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Fig. 6 a GDNF microspheres provided significant recove1y of PLR 
function compared to control blank rnicrospheres, starting 10 days 
post ischemic insult. b BDNF showed an immediate positive effect on 
the group which received blank microspheres when all 
testing parameters were compared. 
Morphometric analysis 
Since this model of acute retinal ischemia-reperfusion 
mJury is characterized by severe damage of all retinal 
layers and particularly in the region of the central retina 
(17], detailed morphometric analysis was perfonned to 
determine possible preservation of retinal strncture after 
application of neurotrophic growth factors (Fig. 8). Statis-
tical analysis showed significant difference in the total 
retinal thickness and thickness of the outer nuclear layer 
between the GDNF-treated and non-treated (ischemia-
induced but non-treated) rat eyes: GDNF101.1=99.7±6 µm 
25 
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Fig. 7 Electroretinography analysis revealed significantly better cone 
fiinction in those operated eyes that received GDNF, CNTF or blank 
lllicrospheres than in eyes which had retinal ischemic episode but did 
not receive any intraocular injection (bars represent standard error of 
niean, * represents p<0.05, OPs=oscillato1y potentials). Bars repre-
sent mean+ SEM 
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retinal function which was sustained until the end of the experiment. 
Values are plotted as mean±SEM 
(mean ± SEM) and non-treated101• 1=51.4±2.2 µm (p< 
0.0001, Student's t-test) and GDNFoNL =46.3±9 µm and 
non-treatedoNL =20± 1.8 µm (p=0.0029, Student's t-test). 
Analysis of remaining parameters between all treated 
groups showed no statistically significant difference. 
Discussion 
The experimental approach used in this study allowed us to 
precisely monitor dynamics of functional recovery in eyes 
exposed to acute elevation of intraocular pressure, followed 
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Fig. 8 Morphometric analysis showed significant preservation of 
retinal structure in the GDNF-treated group when compared to 
animals which did not receive intraocular injection. However, 
difference was not significant when data were compared with ischemic 
eyes which received blank microspheres (bars represent standard error 
of mean, ** represents p<0.01, *** represents p<0.0001). Bars 
represent mean±SEM 
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by chronic delivery of different neurotrophic factors for a 
prolonged period of time (up to 8 weeks). 
It has been previously demonstrated that analysis of the 
PLR and ERG responses is an effective and sensitive 
strategy for monitoring retinal and optic nerve status after 
acute ocular hypertension (ischemia-reperfusion) injury 
and glaucoma in rodents [15-17, 24-26]. Previous studies 
showed that rodent retinas exposed to acute and chronic 
elevation of IOP have a strong intrinsic capacity to 
temporarily recover optic nerve function. However, the 
exact nature of molecular changes responsible for observed 
functional recovery has not been identified [15-17]. Data 
from this study are strongly suggestive of an intrinsic 
CNTF up-regulation as a possible mechanism responsible 
for the observed temporary functional recovery in rodent 
retinas exposed to acute ischemic insult, since microarray 
analysis of retinal tissue did not reveal up-regulation of any 
other molecules with possible neurotrophic or neuroprotec-
tive properties. The majority of observed gene changes 
were suggestive of the reactive glial status and inflamma-
tory response, which could be a cause or just a reactive 
consequence of ongoing neuronal death in ischemic retinas. 
However, we can not absolutely exclude possible role of 
other molecules being responsible for obse1ved intrinsic 
functional recovery in this model. Experiments with 
blockade of CNTF activity or use of CNTF knockout 
animals would be needed to absolutely confirm the role of 
CNTF as the major driver of the observed intrinsic 
functional recovery. Intrinsic up-regulation of neurotrophic 
factors in retinal tissue has been described as a feature of many 
different models of optic nerve and retinal injury [27-33]. 
Different studies have shown up-regulation of growth factor 
production predominantly in Miiller glial cells in eyes with 
optic nerve injury or different forms of retinal degeneration 
[34, 35]. It has been also demonstrated that activated 
microglia can produce neurotrophic factors, which may 
promote neuronal srnvival [36]. 
This study demonstrated that exogenous supplementa-
tion with CNTF in rats with acute ischemia-reperfusion 
injury is not an effective strategy for improvement of 
functional parameters. While the reason for the observed 
lack of CNTF efficacy in this study can not be precisely 
determined from performed experiments, it can be specu-
lated that spontaneous intrinsic production of this molecule 
probably occupied the majority (or all) of available 
receptors, and prevented any additional therapeutic effect 
of exogenously supplemented CNTF. Although significant-
ly better flicker ERG function was noticed in CNTF-treated 
eyes, this difference was significant only when a compar-
ison was made against non-treated operated rats. 
Observed data from GDNF and BDNF treated rats may 
se1ve as additional evidence to supp01t the hypothesis that 
intrinsic expression of specific growth factors can mediate 
~Springer 
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possible outcomes of exogenous neurotrophic factor appli-
cation. While animals which did not receive any treatment 
or received treatment with blank microspheres showed 
tempormy functional recovety at 35 days, the development 
of functional decline resulted in dramatic worsening of the 
optic nerve function at later time points. Since GDNF- and 
BDNF-treated eyes had overall better optic nerve function 
observed by PLR analysis, and functional decline after 
35 days postoperatively was not obse1ved in GDNF- and 
BDNF-treated eyes, it is likely that targeted therapy with 
specific neurotrophic growth factors resulted in effective 
neuroprotection in ischemic retinas. Furthermore, GDNF 
and BDNF mRNA increase was not detected in ischemic 
rodent retinas at 10 and 25 days post injury, so we can 
speculate that these neurotrophic growth factors do not 
have a role in the intrinsic spontaneous recovery of optic 
netve function. Considering relatively unchanged levels of 
GDNF and BDNF mRNA levels (and their respective 
receptors), it is likely that a sufficient amount of target 
receptors was available in the retinal tissue, which probably 
allowed exogenously supplied growth factors to potentiate 
intrinsic mechanisms of functional optic nerve recovery 
observed by PLR analysis. The GDNF group also had 
much better prese1vation of cone function (flicker ERG) 
and retinal structure (observed by retinal morphometry) 
when compared to non-treated operated eyes. We have also 
observed positive effects of CNTF, GDNF and blank 
microspheres on flicker ERG; however, pupil light reflex 
activity showed significantly better outcome only in 
GDNF-treated eyes. Considering that pupil response is a 
summated response of the photoreceptors, inner retinal 
neurons and retinal ganglion cells, it is possible that CNTF 
and blank microspheres had some positive effects on cone 
function; however, lack of PLR improvement is highly 
suggestive of the absent neuroprotective effects on the optic 
nerve itself. 
Based on these observations, we can speculate that 
neurotrophic growth factors may protect retinal function 
against ischemic insult only if exogenously applied neuro-
trophic factors are not already intrinsically produced at 
maximal therapeutic concentrations in the affected tissue. 
Conclusion 
Exogenous application of neurotrophic growth factors via 
polymer biodegradable microspheres has been an effective 
strategy for retinal neuroprotection [8]; however, different 
studies have also demonstrated potential negative effects of 
these molecules on retinal neurons [37, 38]. While the 
model of retinal ischemia-reperfusion injury does not 
represent a true clinical situation in human patients, . the 
findings observed in this study may provide useful guide· 
Graeles Arch Clin Exp Ophthalmol (2010) 248:1105-lll6 
-
Jines, which should be considered during selection of 
11eurotrophic growth factors for possible therapeutic use in 
different ocular neurodegenerative diseases. With advance-
rnents of genomic and protcomic analysis of tissue from 
human donors suffering from different ocular diseases, it is 
likely that profiles of different neurotrophic growth factors 
and their respective receptors will become widely available. 
That data should provide excellent baseline parameters for 
111ore rational selection of specific therapeutic molecules, 
which may dramatically improve therapeutic outcome of 
growth-factor-based therapies for different ocular diseases. 
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